Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

[Dr Jean Languillon (1912-2003), a major unrecognized leprologist].

Louis J, Louis F. Medecine tropicale et sante internationale. 2023; 3 (2) : 1-7.
Download PDF
Publication

[Analysis of national leprosy surveillance data in Mauritania from 2009 to 2019].

Boushab B, Yanogo P, Barry D, et al. Medecine tropicale et sante internationale. 2023; 3 (2) : 1-8.
Download PDF
Publication

Effectiveness of innovative interventions on curbing transmission of Mycobacterium leprae

Ortuño-Gutiérrez N. Erasmus University Rotterdam. 2023;
Download PDF
Publication

Alarming information on human leprosy cases in the Zona da Mata Rondoniense region, Western Amazon, Brazil

Barbosa EF, Barbosa KCDA, Mira ÁBD, et al. Even3. Scientia Naturalis. 2023; 5 (1) : 225-237.
Download PDF
Publication

Leprosy and tuberculosis control scenario of the national program for the improvement of access and quality of primary care in Brazil

Ferreira GRON, Miranda ALC, Farias VA, et al. Springer Science and Business Media LLC. BMC Health Services Research. 2023; 23 (1) : 1-10.
Download PDF
Practical material

NTD Inclusion Score Card (NISC) Tool

ILEP & InfoNTD. 2023;
Publication

Prevalência de Mycobacterium leprae no município de Chapadinha - MA entre os anos de 2017-2022

Santos RDJS, Monteles AS, Silva CGD. Research, Society and Development. Research, Society and Development. 2023; 12 (7) : 1-10.
Download PDF
Publication

Os casos recidivas de hanseníase na área urbana de Barra do Garças-MT

de Sousa R. R, Zucherato B, Cristiano de Melo S, et al. GEOARAGUAIA. 2023;
Download PDF
Publication

Effectiveness of neurolysis as a treatment for complications of leprosy neuritis: a systematic review

Gonçalves LC, Fuentealba-Torres M, Bolorino N, et al. FapUNIFESP (SciELO). Revista da Sociedade Brasileira de Medicina Tropical. 2023;
Download PDF
Publication

The magnitude and associated factors of ocular lesions/complications among leprosy patients treated at Boru Meda General Hospital, Ethiopia: Cross-sectional study design, 2021

Bayuh F. B, Gelaye K. A, Dawed Y. A, et al. Science Set Journal of Ophthalmology and Eye Care. 2022;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 144
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD